Apyx Medical
APYX
41 hedge funds and large institutions have $26.6M invested in Apyx Medical in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 9 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 6
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
5% more funds holding
Funds holding: 39 → 41 (+2)
6% less capital invested
Capital invested by funds: $28.2M → $26.6M (-$1.55M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Archon Capital Management
Seattle,
Washington
|
+$6.66M |
| 2 |
RA
Royce & Associates
New York
|
+$2.05M |
| 3 |
RI
RTW Investments
New York
|
+$1.91M |
| 4 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$825K |
| 5 |
WPC
White Pine Capital
Bloomington,
Minnesota
|
+$791K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$6.18M |
| 2 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$1.66M |
| 3 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$676K |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$491K |
| 5 |
IAM
ICM Asset Management
Spokane,
Washington
|
-$40K |
APYX Hedge Fund Activity: Q4 2017 in Review
41 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q4 2017, worth a combined $26.6M — down 5.5% from $28.2M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new APYX positions and 9 closed out — a net gain of 2 holders — while 14 added to existing stakes and 6 trimmed.
The largest buyer was Archon Capital Management, adding an estimated $6.66M. The largest seller was Great Point Partners, exiting entirely with an estimated $6.18M sold.
- 41 institutional investors held Apyx Medical (APYX) as of Q4 2017, up from 39 in Q3 2017.
- Funds reported $26.6M of Apyx Medical stock for Q4 2017, down 5.5% quarter-over-quarter.
- 11 funds opened new Apyx Medical positions in Q4 2017 and 9 closed out, a net change of +2 holders.
- The largest Apyx Medical buyer in Q4 2017 was Archon Capital Management, an estimated $6.66M added.
- The largest Apyx Medical seller in Q4 2017 was Great Point Partners, an estimated $6.18M sold.
Based on aggregated 13F filings for Q4 2017.